AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
1.380
-0.090 (-6.12%)
Dec 5, 2025, 4:00 PM EST - Market closed
AIM ImmunoTech Stock Forecast
AIM's stock price has decreased by -93.33% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for AIM ImmunoTech stock has a target of 24, which predicts an increase of 1,639.13% from the current stock price of 1.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 3, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for AIM ImmunoTech is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $150 → $24 | Strong Buy | Maintains | $150 → $24 | +1,639.13% | Oct 3, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5 → $4.5 | Strong Buy | Maintains | $5 → $4.5 | +226.09% | Dec 10, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $2 → $1 | Strong Buy | Maintains | $2 → $1 | -27.54% | Oct 22, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5.25 → $5 | Strong Buy | Maintains | $5.25 → $5 | +262.32% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
71.21K
from 170.00K
Decreased by -58.11%
Revenue Next Year
101.00K
from 71.21K
Increased by 41.84%
EPS This Year
-6.88
from -30.92
EPS Next Year
-3.41
from -6.88
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 105,000 | 105,000 | ||||
| Avg | 71,205 | 101,000 | ||||
| Low | 40,180 | 98,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -38.2% | 47.5% | ||||
| Avg | -58.1% | 41.8% | ||||
| Low | -76.4% | 37.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -7.13 | -2.37 | |
| Avg | -6.88 | -3.41 | |
| Low | -6.69 | -4.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.